Cinitapride
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171932This classification denotes a serotonin antagonist and serotonin agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R8I97I2L24. European Medicines Agency schedules Cinitapride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06298MIG. Cinitapride generally arises in the molecular formula C21H30N4O4. The term CINITAPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, no. 10 1979, list 19.) CINITAPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinitapride under HS 29333999 and SITC 51574. As of Q4 2014, CINITAPRIDE remains the US FDA Preferred Term for this commodity. Cinitapride bears US NLM identifiers UMLS ID C0055747 and NCI Concept Code C77257. SMILES: O=C(NC1CCN(CC2CCC=CC2)CC1)C1C(OCC)CC(N)C([N](=O)O)C1.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.